Novavax says it’s developing COVID-19 vaccine to target new Omicron variant

Posted by on November 26, 2021 7:17 pm
Categories: Global Stories

The vaccine developer said it had started developing a spike protein specifically based on the known genetic sequence of the variant, B.1.1.529.

Leave a Reply

Your email address will not be published.